Analysts on Wall Street Lower Ratings for These 5 Stocks

In this article, we discuss the 5 stocks receiving downgrades from analysts. If you want to see more such stocks on the list, go directly to Analysts on Wall Street Lower Ratings for These 10 Stocks.

05. Merck & Co., Inc. (NYSE:MRK)

Price Reaction after the Downgrade: -0.73 (-0.59%)

On March 11, Merck & Co., Inc. (NYSE:MRK), a prominent player in the pharmaceutical industry, experienced a noteworthy event in the stock market. Societe Generale, a reputable financial institution, downgraded its rating on Merck & Co., Inc. (NYSE:MRK) from “Hold” to “Sell” while setting a price target of $104.00. This downgrade marked a shift in perception regarding the company’s performance and potential. As a consequence of this downgrade, the market price of Merck & Co., Inc. (NYSE:MRK) saw a decline of 0.59% by the closing bell on March 11, settling at $122.94. This adjustment in market value reflects investor sentiment following Societe Generale’s assessment, indicating a cautious outlook on Merck & Co., Inc. (NYSE:MRK) future prospects.